Cargando…
NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
BACKGROUND: In Peru, 32,970 people were diagnosed with tuberculosis (TB) in 2019. Although TB treatment is effective, 3.4%–13% is associated with significant adverse drug reactions (ADR), considering drug‐induced liver injury (DILI) as the most prevalent. Among the first‐line anti‐TB drugs, isoniazi...
Autores principales: | Jaramillo‐Valverde, Luis, Levano, Kelly S., Tarazona, David D., Capristano, Silvia, Zegarra‐Chapoñan, Roberto, Sanchez, Cesar, Yufra‐Picardo, Velia M., Tarazona‐Santos, Eduardo, Ugarte‐Gil, Cesar, Guio, Heinner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356556/ https://www.ncbi.nlm.nih.gov/pubmed/35751408 http://dx.doi.org/10.1002/mgg3.1987 |
Ejemplares similares
-
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients
por: Levano, Kelly S., et al.
Publicado: (2021) -
GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients
por: Jaramillo-Valverde, Luis, et al.
Publicado: (2022) -
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration
por: Jaramillo-Valverde, Luis, et al.
Publicado: (2021) -
Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire
por: Harris, Daniel N., et al.
Publicado: (2018) -
A Genomic Signature for Genotyping Mycobacterium tuberculosis
por: Tarazona, David, et al.
Publicado: (2017)